Beta-Cell's Other Investors

Beta-Cell raised a round of funding on , . Investors include Life Sciences Research Partners.

Beta-Cell is a privately owned biopharmaceutical company that develops novel cell therapies and other products related to Diabetes. Beta-Cell's lead product, BetaGraft1.0, is a novel cell replacement…

Articles about Beta-Cell's Other Investors: